Vismodegib
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 980 publications
Resistance to SMO Inhibitors in Advanced Basal Cell Carcinoma: A Case Highlighting the Role of Molecular Tumor Profiling.
Journal: International journal of molecular sciences
Published: December 04, 2025
Alcian blue-positive stromal phenotype in basal cell carcinoma is associated with progression on first-line hedgehog inhibitors.
Journal: The journal of pathology. Clinical research
Published: October 22, 2025
Low-dose oral minoxidil for the management of vismodegib-induced alopecia.
Journal: JAAD case reports
Published: October 17, 2025
A cell-based Sonic hedgehog signaling transduction system to identify additive and synergistic chemical interactions.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: October 15, 2025
Chondrosarcoma organoids reveal SHH pathway activation driven by PTCH1 and BCOR alterations.
Journal: Scientific reports
Published: October 10, 2025
Divergent late stage functionalisation of luminescent europium(III) complexes for targeting and imaging applications.
Journal: Chemical communications (Cambridge, England)
Published: October 09, 2025
Phase II Study of Vismodegib in Patients With SMO- or PTCH1-Mutated Tumors: Results From the National Cancer Institute Molecular Analysis for Therapy Choice Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Trial (EAY131) Subprotocol T.
Journal: JCO precision oncology
Published: October 09, 2025
Real-World Treatment Patterns of Patients with Basal Cell Carcinoma Using Sonidegib and Vismodegib: Discontinuation Rates and Clinical Conditions During Treatment.
Journal: Dermatology and therapy
Published: September 29, 2025
Activated T cells degrade extracellular proteins to enhance effector functions.
Journal: Cell reports
Published: September 16, 2025
Vismodegib and Sonidegib Are Associated With an Elevated Reporting Odds of Squamous Cell Carcinoma; a Comparative Pharmacovigilance Study of the FDA Adverse Events Reporting System (FAERS).
Journal: The Australasian journal of dermatology
Published: September 15, 2025
A case of basal cell nevus syndrome with a SUFU mutation.
Journal: Dermatology online journal
Published: August 28, 2025
Last Updated: 02/24/2026